Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Revenue
Revenues	$ 179,126	$ 1,764
Operating expenses
Research and development	4,120	8,959
General and administrative	5,889	5,832
Change in fair value of contingent consideration	209	299
Restructuring costs	0	12,373
Total operating expenses	10,218	27,463
Income (loss) from operations	168,908	(25,699)
Interest income	815	1,197
Interest expense	(17)	(28)
Foreign exchange (loss) gain	(11)	4
Total other income	787	1,173
Net income (loss)	$ 169,695	$ (24,526)
Net income (loss) per common share
Basic (in USD per share)	$ 0.88	$ (0.13)
Diluted (in USD per share)	$ 0.87	$ (0.13)
Weighted average number of common shares
Basic (in shares)	193,768,641	190,707,085
Diluted (in shares)	195,214,067	190,707,085
Comprehensive income (loss)
Unrealized loss on available-for-sale securities	$ (97)	$ (31)
Comprehensive income (loss)	169,598	(24,557)
Collaborations and licenses
Revenue
Revenues	204	1,316
Revenue from collaborations and licenses
Revenue
Revenues	178,741	0
Non-cash royalty revenue
Revenue
Revenues	$ 181	$ 448